Pentostatin Injection

[05 September 2014]

Products Affected - Description

Pentostatin 10 mg powder (NDC 55390-0244-01), West-Ward (formerly Bedford product)

Reason for the Shortage

West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired several products from Bedford Laboratories in July 2014 including pentostatin injection. West-Ward is not actively marketing pentostatin.

Available Products

Nipent 10 mg powder (NDC 00409-0801-01), Hospira

Estimated Resupply Dates

Hospira has Nipent readily available.

Related Shortages


September 5, 2014; June 24, 2014; April 9, 2014; January 13, 2014; November 14, 2013; September 19, 2013; July 16, 2013; April 25, 2013; February 8, 2013; December 19, 2012; October 9, 2012; July 25, 2012; June 20, 2012; April 23, 2012; March 20, 2012; March 5, 2012; February 28, 2012; January 24, 2012; December 21, 2011, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing